Fujifilm Diosynth Biotechnologies begins Covid-19 vaccine candidate production in College Station
The company recently completed its previously announced capacity expansion at its Flexible Biomanufacturing Facility, which accommodates large-scale production of the Covid-19 vaccine candidates, and has added about 260 positions since April 2020 with about 50 more to come.
